Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Alimera Sciences Inc. (ALIM)

0.85   0.026 (3.11%) 01-18 15:59
Open: 0.83 Pre. Close: 0.8244
High: 0.87 Low: 0.8102
Volume: 117,807 Market Cap: 60M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.871 - 0.876 0.876 - 0.881
Low: 0.798 - 0.804 0.804 - 0.809
Close: 0.841 - 0.85 0.85 - 0.858

Technical analysis

as of: 2019-01-18 4:28:58 PM
Overall:       
Stoxline posted a NEUTRAL today, upgraded from lower rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are.
Target: Six months: 1.05     One year: 1.18
Support: Support1: 0.72    Support2: 0.60
Resistance: Resistance1: 0.90    Resistance2: 1.01
Pivot: 0.85
Moving Average: MA(5): 0.83     MA(20): 0.84
MA(100): 0.98     MA(250):
MACD: MACD(12,26): -0.02     Signal(9): -0.03
Stochastic oscillator: %K(14,3): 45.33     %D(3): 45.33
RSI: RSI(14): 45.82
52-week: High: 1.34  Low: 0.72  Change(%): -26.7
Average Vol(K): 3-Month: 9563  10-Days: 10184

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
ALIM has closed below upper band by 47.7%. Bollinger Bands are 11.6% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2019-01-07T07:47:30-05:00
Alimera Sciences affirms record Q4 and FY2018 revenues

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
atoplab.com
Tweet this page Share on Google+ Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Drug Manufacturers - Major
Shares Out. (M) 70.08
Shares Float (M) 69.15
% Held by Insiders 1.30
% Held by Institutions 60.70
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS -0.290
EPS Est. Current Year -0.210
EPS Est. Next Year -0.080
EPS Est. Next Quarter -0.020
Forward EPS -0.020
Book Value (p.s.) 12.980
PEG Ratio
Profit Margin -47.51
Operating Margin -37.76
Return on Assets (ttm) 19.5
Return on Equity (ttm) -30.0
Qtrly Rev. Growth 13.8
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -13.92
Levered Free Cash Flow (M) -6.87

Stock Valuations

P/E -2.93
P/E Growth Ratio 0.04
P/BV 0.07
P/S 100962712.00
P/CF -4.28

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.